# A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial

> **NCT05038397** · NA · COMPLETED · sponsor: **MedicalExcellence** · enrollment: 30 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DEVICE:** Theraspere

## Key facts

- **NCT ID:** NCT05038397
- **Lead sponsor:** MedicalExcellence
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05038397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05038397, "A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05038397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
